Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-25-006993
Filing Date
2025-02-21
Accepted
2025-02-21 09:00:24
Documents
86
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K itci-20241231.htm   iXBRL 10-K 1794575
2 EX-3.1 itci-20241231xex31.htm EX-3.1 84323
3 EX-4.2 itci-20241231xex42.htm EX-4.2 15758
4 EX-19 itci-20241231xex19.htm EX-19 104593
5 EX-23.1 itci-20241231xex231.htm EX-23.1 5018
6 EX-31.1 itci-20241231xex311.htm EX-31.1 7729
7 EX-31.2 itci-20241231xex312.htm EX-31.2 7772
8 EX-32.1 itci-20241231xex321.htm EX-32.1 4593
14 itci-20241231_g1.jpg GRAPHIC 151593
  Complete submission text file 0001628280-25-006993.txt   8615961

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itci-20241231.xsd EX-101.SCH 47386
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT itci-20241231_cal.xml EX-101.CAL 84208
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT itci-20241231_def.xml EX-101.DEF 192884
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itci-20241231_lab.xml EX-101.LAB 665342
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itci-20241231_pre.xml EX-101.PRE 447209
89 EXTRACTED XBRL INSTANCE DOCUMENT itci-20241231_htm.xml XML 1064960
Mailing Address 135 ROUTE 202/206 SUITE 6 BEDMINSTER NJ 07921
Business Address 135 ROUTE 202/206 SUITE 6 BEDMINSTER NJ 07921 (646) 440-9333
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36274 | Film No.: 25648589
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)